164 related articles for article (PubMed ID: 10211101)
1. Expression pattern of vascular endothelial growth factor isoform is closely correlated with tumour stage and vascularisation in renal cell carcinoma.
Tomisawa M; Tokunaga T; Oshika Y; Tsuchida T; Fukushima Y; Sato H; Kijima H; Yamazaki H; Ueyama Y; Tamaoki N; Nakamura M
Eur J Cancer; 1999 Jan; 35(1):133-7. PubMed ID: 10211101
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor 189 mRNA isoform expression specifically correlates with tumor angiogenesis, patient survival, and postoperative relapse in non-small-cell lung cancer.
Yuan A; Yu CJ; Kuo SH; Chen WJ; Lin FY; Luh KT; Yang PC; Lee YC
J Clin Oncol; 2001 Jan; 19(2):432-41. PubMed ID: 11208836
[TBL] [Abstract][Full Text] [Related]
3. Tubulogenesis by microvascular endothelial cells is mediated by vascular endothelial growth factor (VEGF) in renal cell carcinoma.
Nakagawa M; Emoto A; Hanada T; Nasu N; Nomura Y
Br J Urol; 1997 May; 79(5):681-7. PubMed ID: 9158500
[TBL] [Abstract][Full Text] [Related]
4. VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma.
Bates DO; Cui TG; Doughty JM; Winkler M; Sugiono M; Shields JD; Peat D; Gillatt D; Harper SJ
Cancer Res; 2002 Jul; 62(14):4123-31. PubMed ID: 12124351
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of gene expressions of vascular endothelial growth factor-related factors and their receptors in renal cell carcinoma.
Tsuchiya N; Sato K; Akao T; Kakinuma H; Sasaki R; Shimoda N; Satoh S; Habuchi T; Ogawa O; Kato T
Tohoku J Exp Med; 2001 Oct; 195(2):101-13. PubMed ID: 11846206
[TBL] [Abstract][Full Text] [Related]
6. Quantification by competitive quantitative RT-PCR of VEGF121 and VEGF165 in renal cell carcinoma.
Thelen P; Hemmerlein B; Kugler A; Seiler T; Ozisik R; Kallerhoff M; Ringert RH
Anticancer Res; 1999; 19(2C):1563-5. PubMed ID: 10365146
[TBL] [Abstract][Full Text] [Related]
7. Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma.
Lee YH; Tokunaga T; Oshika Y; Suto R; Yanagisawa K; Tomisawa M; Fukuda H; Nakano H; Abe S; Tateishi A; Kijima H; Yamazaki H; Tamaoki N; Ueyama Y; Nakamura M
Eur J Cancer; 1999 Jul; 35(7):1089-93. PubMed ID: 10533453
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor expression, angiogenesis, and necrosis in renal cell carcinomas.
Hemmerlein B; Kugler A; Ozisik R; Ringert RH; Radzun HJ; Thelen P
Virchows Arch; 2001 Nov; 439(5):645-52. PubMed ID: 11764385
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor (VEGF) mRNA expression in human tumor models of different histologies.
Berger DP; Herbstritt L; Dengler WA; Marmé D; Mertelsmann R; Fiebig HH
Ann Oncol; 1995 Oct; 6(8):817-25. PubMed ID: 8589021
[TBL] [Abstract][Full Text] [Related]
10. [Correlation of neovascularization and vascular endothelial growth factor in human renal cell carcinoma].
Sato K; Kato T
Gan To Kagaku Ryoho; 1997 Feb; 24(4):389-94. PubMed ID: 9063473
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer.
Tokunaga T; Oshika Y; Abe Y; Ozeki Y; Sadahiro S; Kijima H; Tsuchida T; Yamazaki H; Ueyama Y; Tamaoki N; Nakamura M
Br J Cancer; 1998 Mar; 77(6):998-1002. PubMed ID: 9528847
[TBL] [Abstract][Full Text] [Related]
12. Different isoform patterns for vascular endothelial growth factor between clear cell and papillary renal cell carcinoma.
Jacobsen J; Grankvist K; Rasmuson T; Ljungberg B
BJU Int; 2006 May; 97(5):1102-8. PubMed ID: 16643499
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis in renal cell carcinoma: Evaluation of microvessel density, vascular endothelial growth factor and matrix metalloproteinases.
Zhang X; Yamashita M; Uetsuki H; Kakehi Y
Int J Urol; 2002 Sep; 9(9):509-14. PubMed ID: 12410931
[TBL] [Abstract][Full Text] [Related]
14. Different vascular endothelial growth factor (VEGF), VEGF-receptor 1 and -2 mRNA expression profiles between clear cell and papillary renal cell carcinoma.
Ljungberg BJ; Jacobsen J; Rudolfsson SH; Lindh G; Grankvist K; Rasmuson T
BJU Int; 2006 Sep; 98(3):661-7. PubMed ID: 16925769
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor - its relation to neovascularization and their significance as prognostic factors in renal cell carcinoma.
Song KH; Song J; Jeong GB; Kim JM; Jung SH; Song J
Yonsei Med J; 2001 Oct; 42(5):539-46. PubMed ID: 11675683
[TBL] [Abstract][Full Text] [Related]
16. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
17. Histopathological analysis of angiogenic factors in renal cell carcinoma.
Yagasaki H; Kawata N; Takimoto Y; Nemoto N
Int J Urol; 2003 Apr; 10(4):220-7. PubMed ID: 12657102
[TBL] [Abstract][Full Text] [Related]
18. Expression of vascular endothelial growth factor in renal cell carcinoma and the relation to angiogenesis and p53 protein expression.
Lee JS; Kim HS; Jung JJ; Park CS; Lee MC
J Surg Oncol; 2001 May; 77(1):55-60. PubMed ID: 11344484
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor expression is increased in renal cell carcinoma.
Nicol D; Hii SI; Walsh M; Teh B; Thompson L; Kennett C; Gotley D
J Urol; 1997 Apr; 157(4):1482-6. PubMed ID: 9120987
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor splice variants and their prognostic value in breast and ovarian cancer.
Stimpfl M; Tong D; Fasching B; Schuster E; Obermair A; Leodolter S; Zeillinger R
Clin Cancer Res; 2002 Jul; 8(7):2253-9. PubMed ID: 12114428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]